Afya (NASDAQ:AFYA - Get Free Report) is scheduled to release its earnings data after the market closes on Wednesday, November 13th. Analysts expect Afya to post earnings of $0.34 per share for the quarter. Afya has set its FY 2024 guidance at EPS.
Afya (NASDAQ:AFYA - Get Free Report) last released its earnings results on Thursday, August 15th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.35 by $0.06. The business had revenue of $155.40 million during the quarter, compared to analyst estimates of $151.83 million. Afya had a net margin of 18.12% and a return on equity of 18.82%. On average, analysts expect Afya to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Afya Price Performance
Shares of NASDAQ:AFYA traded down $0.44 during midday trading on Tuesday, hitting $17.52. 107,809 shares of the stock were exchanged, compared to its average volume of 132,249. Afya has a twelve month low of $14.64 and a twelve month high of $22.48. The stock has a market cap of $1.64 billion, a P/E ratio of 14.84, a PEG ratio of 0.37 and a beta of 0.91. The company has a 50 day moving average price of $16.74 and a 200-day moving average price of $17.29. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 0.40.
Analyst Upgrades and Downgrades
Separately, UBS Group assumed coverage on Afya in a report on Friday, August 30th. They set a "neutral" rating and a $19.50 price objective on the stock.
Check Out Our Latest Research Report on AFYA
About Afya
(
Get Free Report)
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
See Also
Before you consider Afya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.
While Afya currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
